Stevens Institute of Technology is exploring the leading frontiers of health and medicine, developing the next medications, therapies, devices, diagnostic systems and other applications to help make our lives longer, healthier and more comfortable.
Stevens deploys a comprehensive, university-wide effort — and the very latest technologies, including AI — to address the vital health and medical challenges of our time.
The university expands its flagship healthcare research center, reorganized around five research clusters tuned to optimize societal impact.
Stevens regularly invites today’s thought leaders in health and medicine to campus to speak, including Bristol Myers Squibb CEO Giovanni Caforio, Pfizer Senior VP for Operations Tanya Alcorn and AstraZeneca Executive Vice President Pam Cheng.
Stevens' research in health and medicine, collected under the auspices of the Semcer Center for Healthcare Innovation (CHI), incorporates talent from across the university
We take advantage of collaborations to maximize our impact in this important field. Our researchers make a team effort, both across disciplines and schools here at Stevens and also by building new and existing collaborations with industry and medical and clinical partners.
Hongjun Wang
Director, Semcer Center for Healthcare Innovation (CHI)
We take advantage of collaborations to maximize our impact in this important field. Our researchers make a team effort, both across disciplines and schools here at Stevens and also by building new and existing collaborations with industry and medical and clinical partners.
Hongjun Wang
Director, Semcer Center for Healthcare Innovation (CHI)
We take advantage of collaborations to maximize our impact in this important field. Our researchers make a team effort, both across disciplines and schools here at Stevens and also by building new and existing collaborations with industry and medical and clinical partners.
Hongjun Wang
Director, Semcer Center for Healthcare Innovation (CHI)
Stevens researchers are leveraging AI, wearable sensors and other leading-edge technologies in a growing effort to help predict and diagnose cardiac diseases earlier.
Stevens researchers use AI-powered applications to sense trouble in the recorded sounds of blood flowing through our veins and arteries.
Yu Gan develops AI-based techniques to clarify medical imaging of hearts, arteries — even pregnancies.
Supported by NASA, Stevens develops wireless monitors that use radar and cameras to read multiple people's vital signs at once.
Stevens graduate Pam Cheng '92 M.Eng. '95 serves as Executive Vice President of one of the world's largest pharmaceutical companies, AstraZeneca
Stevens is helping transform the future of health and medicine
Stevens researchers are understanding the brain in new ways, modeling, detecting and predicting Alzheimer’s disease, dementia, epilepsy, concussions and other neurodegenerative disorders
Stevens Professor Johannes Weickenmeier approaches and analyzes neurodegenerative diseases from a new perspective: as mechanical (and predictable) events.
A Stevens researcher develops an AI-powered system that can sense epileptic seizures beginning in the brain almost immediately.
New Stevens research uncovers the possibility that diminishing mental capacity as we age may be caused or worsened by the physical pressures of fluids inside the brain.
Stevens researcher Jennifer Kang-Mieler develops novel imaging and drug-delivery techniques to early-diagnose and treat diabetic ocular disorders caused by diabetes.
Multiple Stevens research teams investigate a host of solid and liquid cancers.
Stevens faculty and student researchers are identifying new drug candidates, developing therapeutic and diagnostic tools.
New research with a major medical center reveals that gold-nanoparticle packages ferry cancer drugs precisely.
Two Stevens researchers use National Cancer Institute support to design new ways of imaging — and understanding — the ways in which ovarian cancers spread, even after treatment.
Stevens researchers use AI, VR, wearable sensors and other technologies to improve our health, performance and recovery from injury.
With MLB’s support, Stevens biomedical engineer Antonio Zaferiou analyzes pitchers’ biomechanics to reduce strain, enhance power and improve coaching
Stevens researcher Ravi Nataraj uses the new tools of VR to assist and upgrade rehabilitation from spinal-cord and other injuries.
The new research center at Stevens is positioned to help shape the future of electrical and computer engineering technologies.
Matt Libera heads a leading-edge effort at Stevens to prevent and battle infections created by prosthetics, transplants and other medical interventions.
NIH grants Stevens researcher Shang Wang $1.9 million award to improve the power of optical coherence tomography imaging techniques.
Led by Stevens computer scientist Samantha Kleinberg, researchers mine a firehose of medical data to identify useful trends and spot disease patterns.
Stevens joins a sweeping new NIH effort that will use AI to determine how what we eat affects our health.
Doctoral candidate Louis Gomez develops AI-based systems to monitor and predict blood-glucose levels of diabetic patients and assess stroke patients
Stevens develops research to improve accurate assessments of consciousness in intensive-care units, aiding family and physician decision-making during critical periods.
Stevens researchers are leveraging computational chemistry and other techniques to identify promising new classes of candidate medicines.
Stevens researcher Abhishek Sharma works to ID promising new classes of cancer drugs.
This Stevens undergraduate searches relentlessly for new molecules that could one day lead to new medications.
Stevens professor Dr. Robert Chang and his team are exploring leading-edge technologies to bioprint human tissues in 3D that could soon help address a critical shortage of transplant organs and tissues. [Credit: ASME]